Richard L. Shapiro
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Immunology top 2%
- Surgery top 5%
- Co-authors
- Iman OsmanRussell S. BermanAnna C. PavlickFarbod DarvishianDaniel B. RifkinDaniel F. RosesDavid PolskyRuth Oratz
- Topics
- Cutaneous Melanoma Detection and Management (52 papers)Immunotherapy and Immune Responses (29 papers)Melanoma and MAPK Pathways (27 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyThe Journal of Cell Biology
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Richard L. Shapiro
139 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 2.5k
- Molecular Biology 2.4k
- Cancer Research 1.6k
- Immunology 1.1k
- Surgery 720
Countries citing papers authored by Richard L. Shapiro
This map shows the geographic impact of Richard L. Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard L. Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard L. Shapiro more than expected).
Fields of papers citing papers by Richard L. Shapiro
This network shows the impact of papers produced by Richard L. Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard L. Shapiro. The network helps show where Richard L. Shapiro may publish in the future.
Co-authorship network of co-authors of Richard L. Shapiro
This figure shows the co-authorship network connecting the top 25 collaborators of Richard L. Shapiro. A scholar is included among the top collaborators of Richard L. Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard L. Shapiro. Richard L. Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 12 | |
| 3 | 14 | |
| 4 | 9 | |
| 5 | 18 | |
| 6 | 65 | |
| 7 | 30 | |
| 8 | 17 | |
| 9 | 38 | |
| 10 | 29 | |
| 11 | 212 | |
| 12 | 56 | |
| 13 | 46 | |
| 14 | 173 | |
| 15 | 34 | |
| 16 | Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors. | 97 |
| 17 | Repression of IL-2 mRNA translation in primary human breast cancer tumor infiltrating lymphocytes | 1 |
| 18 | 3 | |
| 19 | 52 | |
| 20 | 20 |
About Richard L. Shapiro
Richard L. Shapiro is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 142 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (52 papers), Immunotherapy and Immune Responses (29 papers) and Melanoma and MAPK Pathways (27 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.5k citations) and Immunology (1.1k citations). Richard L. Shapiro has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Iman Osman, Russell S. Berman, Anna C. Pavlick, Farbod Darvishian, Daniel B. Rifkin, Daniel F. Roses, David Polsky, Ruth Oratz, Christine Ren and Paolo Mignatti. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.